Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Significant Accounting Policies (Details)

v2.4.0.8
Basis of Presentation and Significant Accounting Policies (Details) (USD $)
3 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2014
Customer Concentration Risk [Member]
Customer
Mar. 31, 2013
Customer Concentration Risk [Member]
Customer
Dec. 31, 2013
Customer Concentration Risk [Member]
Customer
Mar. 31, 2014
Revenues [Member]
Customer Concentration Risk [Member]
Customer 1 [Member]
Mar. 31, 2013
Revenues [Member]
Customer Concentration Risk [Member]
Customer 1 [Member]
Mar. 31, 2014
Revenues [Member]
Customer Concentration Risk [Member]
Customer 2 [Member]
Mar. 31, 2013
Revenues [Member]
Customer Concentration Risk [Member]
Customer 2 [Member]
Mar. 31, 2014
Revenues [Member]
Customer Concentration Risk [Member]
Customer 3 [Member]
Mar. 31, 2014
Accounts Receivable [Member]
Customer Concentration Risk [Member]
Customer 1 [Member]
Dec. 31, 2013
Accounts Receivable [Member]
Customer Concentration Risk [Member]
Customer 1 [Member]
Mar. 31, 2014
Accounts Receivable [Member]
Customer Concentration Risk [Member]
Customer 2 [Member]
Dec. 31, 2013
Accounts Receivable [Member]
Customer Concentration Risk [Member]
Customer 2 [Member]
Mar. 31, 2014
Accounts Receivable [Member]
Customer Concentration Risk [Member]
Customer 3 [Member]
Mar. 31, 2014
Restate Previously Reported Diluted Loss per Share for March 2012 Warrants [Member]
Mar. 31, 2014
Restate Previously Reported Diluted Loss per Share for March 2012 Warrants [Member]
Restatement Adjustment [Member]
Mar. 31, 2014
Restate Previously Reported Diluted Loss per Share for March 2012 Warrants [Member]
Previously Reported [Member]
Restatement [Abstract]                                      
Term of warrants 5 years                                    
Aggregate number of unregistered shares of common stock called by warrants (in shares)     14,834,577                                
Exercise price of shares purchased under warrants (in dollars per share)     $ 1.76                                
Impact of restatement on the reported diluted loss per share (in dollars per share)                                   $ (0.17)  
Diluted net loss per share of common stock (in dollars per share) $ (0.21) $ (0.30)                             $ (0.21)   $ (0.04)
Concentration Risk [Line Items]                                      
Number of major customers       3 2 2                          
Concentration risk, percentage (in hundredths)             47.00% 79.00% 40.00% 18.00% 15.00% 57.00% 73.00% 28.00% 13.00% 12.00%